GleamWall
中文EN

ABT ABBOTT LABORATORIES

Pharmaceutical Preparations · NYSE · SEC CIK 1800 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY10.0%
TTM net income YoY-66.4%
TTM EPS YoY-66.2%
Revenue 3-yr CAGR6.5%
Net income 3-yr CAGR-3.1%

Margins

Gross margin56.9%
Operating margin13.8%
Net margin9.7%
FCF margin14.0%
EBITDA margin17.0%

Returns

ROE9.2%
ROA4.9%
ROIC (approx.)7.1%
Asset turnover0.50x

Leverage & solvency

Liabilities / assets52.3%
Debt / equity0.61x
Current ratio1.45x
Interest coverage6.68x

Cash quality & payout

Operating cash flow / net income1.88x
Accruals ratio-4.3%
Payout ratio92.0%
Capex / revenue4.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$44.33B$41.95B
Cost of revenue$19.32B$18.71B
Gross profit$25.01B$23.24B
R&D expense$2.94B$2.84B
SG&A expense$12.33B$11.70B
Operating income$8.05B$6.83B
Interest expense$493.00M$559.00M
Pretax income$8.47B$7.01B
Income tax$1.94B-$6.39B
Net income$6.52B$13.40B
EBITDA$9.49B$8.16B
EPS (basic)3.737.67
EPS (diluted)3.727.64
Dividends declared per share2.402.24
Weighted avg. shares (diluted)1.75B1.75B
Balance sheet
Cash & equivalents$8.52B$7.62B
Short-term investments$417.00M$351.00M
Receivables$7.93B$6.92B
Inventory$6.49B$6.19B
Current assets$26.00B$23.66B
PP&E, net$11.82B$10.66B
Goodwill$24.04B$23.11B
Intangibles$5.53B$6.65B
Total assets$86.71B$81.41B
Current liabilities$16.50B$14.16B
Short-term debt$3.03B$1.50B
Long-term debt$9.90B$12.62B
Total debt$12.93B$14.12B
Total liabilities$33.94B$33.51B
Shareholders' equity$52.13B$47.66B
Net debt$4.41B$6.51B
Cash flow statement
Operating cash flow$9.57B$8.56B
Capital expenditure$2.17B$2.21B
Free cash flow$7.39B$6.35B
Investing cash flow-$2.42B-$2.34B
Financing cash flow-$6.31B-$5.40B
Depreciation & amortization$1.43B$1.34B
Stock-based compensation$664.00M$673.00M
Dividends paid$4.12B$3.84B
Share buybacks$893.00M$1.29B

Free plan shows the latest 2 periods; Pro shows all 19 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.